Atrial Fibrillation Surgery Market (Latest Report) Size, Share and Analysis 2024-2030
Rising incidence of AF worldwide and the rising demand for cutting-edge treatment options are the main driver of growth in the atrial fibrillation surgery market
The market for atrial fibrillation surgery is being driven by factors such as the rising incidence of AF worldwide, the ageing population, and the rising demand for cutting-edge treatment options. The market has expanded as a result of technological developments in surgical procedures and tools like catheter ablation and minimally invasive surgery.
The market's expansion has also been aided by the growing healthcare infrastructure, better reimbursement practices, and rising patient and healthcare professional awareness of the advantages of AF surgery. These elements work together to increase demand for AF surgical interventions and fuel the AF surgery market's expansion.
atrial fibrillation surgery market is expected to grow at 14.5% CAGR from 2023-2030 & predicted to reach above USD 5.85 billion by 2030 from USD 3.01 billion in 2023
Download Sample Report Now: https://marketreportservice.com/request-sample/atrial-fibrillation-surgery-market-54568
Competitive Landscape of the Atrial Fibrillation Surgery Market
- Abbott Laboratories
- AtriCure Inc.
- BIOTRONIK SE and Co KG
- Boston Scientific Corp.
- CardioFocus Inc.
- General Electric Healthcare
- Johnson and Johnson
- Medtronic Plc
- Koninklijke Philips NV
- Siemens Healthineers AG
New Developments in Atrial Fibrillation Surgery Market
04 August 2023 Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
02 March 2023 Advantus Health Partners, and GE HealthCare (Nasdaq: GEHC), announced an agreement of up to USD 760M over 10-years to provide GE HealthCare’s Healthcare Technology Management (HTM) services to Advantus Health Partners’ clients.
high cost of surgical interventions is the major restraints for the atrial fibrillation surgery market
The market for atrial fibrillation (AF) surgery is constrained by the high cost of surgical interventions, potential risks and complications, limited access to specialised centres in some regions, and the preference for non-surgical treatment options.
Another market constraint might be patients' and medical professionals' limited understanding of AF surgery.
The atrial fibrillation surgery market offers several opportunities for growth
Opportunities in the atrial fibrillation (AF) surgery market include rising patient and healthcare professional awareness, expanding surgical techniques and technologies, rising AF treatment demand due to rising prevalence, and improvements in surgical methods and technologies.
Furthermore, opportunities for better outcomes and patient satisfaction are presented by the development of novel and minimally invasive surgical techniques.
COVID 19 had increased demand hybrid operating rooms
The market for atrial fibrillation (AF) surgery has been significantly impacted by the COVID-19 pandemic. Due to resource reallocation and safety concerns, elective surgeries, including AF surgeries, were postponed or cancelled. Procedure backlogs and fewer patient visits had an impact on market expansion.
However, the market is anticipated to pick up steam as healthcare systems improve and vaccination rates rise, driven by unmet demand for surgical treatments for AF.
Ambulatory surgical centre segment is anticipated to hold the largest market share in the atrial fibrillation surgery market based on end user
Due to improved healthcare infrastructure, the availability of skilled labour, and affordability, the ambulatory surgical centre segment is anticipated to experience healthy growth. The market is anticipated to be driven by an expanding patient base and an ageing population with lifestyle diseases like atherosclerosis and heart failure.
But compared to traditional surgeries, the advantages of minimally invasive procedures will eventually spur segment expansion. Benefits like lower surgical pain, injury risk, shorter hospital stays, improved accuracy, and quicker recovery times are pushing patients to choose minimally invasive procedures, which are expected to accelerate market expansion.
North America is dominating the global market for hybrid operating rooms
Due to the high prevalence of atrial fibrillation patients in the region, the North American segment is anticipated to hold a 38% market share during the forecast period of 2022–2030, dominating the atrial fibrillation surgery market. For instance, it was predicted that there would be between 2.7 million and 6.1 million atrial fibrillation patients in the US by 2022, and that number is expected to rise to 12.1 million by 2030. Other factors influencing the segment's growth include the region's favourable reimbursement policies and highly developed healthcare infrastructure.
Buy Complete Report https://marketreportservice.com/buy-now/54568